Search Login Register

temozolomide (Temodar) Summary

Description: structure given in first source

Also Known As: Temodar; 8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; CCRG 81045; CCRG-81045; Essex brand of temozolomide Show All >>

Networked: 2950 relevant articles (349 outcomes, 803 trials/studies) for this Drug

Key Diseases for which temozolomide is Relevant

  1. Glioblastoma (Glioblastoma Multiforme) : 129 outcomes 276 studies in 1188 results
  2. Glioma (Gliomas) : 95 outcomes 220 studies in 897 results
  3. Neoplasms (Cancer) : 62 outcomes 123 studies in 665 results
  4. Melanoma (Melanoma, Malignant) : 32 outcomes 106 studies in 267 results
  5. Neoplasm Metastasis (Metastasis) : 20 outcomes 50 studies in 137 results
Show All >>

Drugs Related to temozolomide

  1. bevacizumab
  2. Dacarbazine (DIC)
  3. Carmustine (FIVB)
  4. Procarbazine (Matulane)
  5. DNA (Deoxyribonucleic Acid)
  6. Alkylating Agents
  7. irinotecan (Camptosar)
  8. Lomustine (CCNU)
  9. capecitabine (Xeloda)
  10. O(6)-Methylguanine-DNA Methyltransferase
Show All >>

Therapies Related to temozolomide

  1. Drug Therapy (Chemotherapy)
  2. Radiotherapy
  3. Heterologous Transplantation (Xenotransplantation)
  4. Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
  5. Conformal Radiotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.